DermorphinDP2

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Cognitive & Neuro Research

Dermorphin

Nociception and analgesic mechanisms

Dermorphin specifications and reference prices. Select a specification to add it to your cart.

2mg/vial x 10vials · DP2
Reference priceUS$81.82

For laboratory research only. Not for human or veterinary use.

COA 检测报告 / Reports

Compare all specifications & reference prices
SKUSpecification / packReference price (USD)
DP22mg/vial x 10vialsUS$81.82
DP52mg/vial x 10vialsUS$139.39
DP1010mg/vial x 10vialsUS$254.55

Temporarily sold-out specifications can still be added to an inquiry to ask about restocking. An inquiry is not an order or an agreed price.

RESEARCH FOCUS

Main Uses & FAQs

This page organizes directly related data on pain perception and analgesic mechanisms of Dermorphin. First, look at the research questions and findings, then check the population or species, study formulations, and scope of interpretation.

Main TopicsPain Perception · Analgesic Mechanisms
USAGE REFERENCE

Dermorphin · Usage reference (for research purposes)

The following presents common research-context references for reconstitution, storage, dosage and cycles. The following presents common references in research settings. This page does not constitute advice for use in humans or animals.

🧪Reconstitution

Suggested Diluent
Bacteriostatic Water (containing 0.9% benzyl alcohol); some peptides may use sterile water or acetic acid to aid dissolution. See the individual product descriptions.
Diluent Volume
Slowly introduce the diluent along the vial wall until the lyophilized powder is covered. A common example is 5 mg reconstituted with 2 mL of bacteriostatic water, yielding approximately 2.5 mg/mL. Referenced reconstitution volumes are approximately 1–2.5 mL, with 2 mL commonly used. It is suggested to select and record a fixed volume based on the COA supplied with the purchase.
Handling Notes
Introduce the diluent slowly along the vial wall rather than directly onto the lyophilized powder. Leave it for 60–90 seconds to dissolve naturally; do not shake vigorously.

💾Storage

Unreconstituted Lyophilized Powder
Refrigerate at 2–8°C, protected from light; avoid repeated freeze–thaw cycles.
After Reconstitution
Refrigerate at 2–8°C; a common recommendation is touse within 28 days; do not freeze.
Transport
For short periods, use insulated packaging with ice packs; avoid high temperatures and direct light.

📏Dosage Reference (Research)

Purpose / SettingCommon Reference
ExplanationAnalgesic mechanism study

Note: The above describes common research-context references, rather than clinical recommendations. Refer to the batch COA and research protocol. For research use only; not for human or animal use.

Research SummaryKey Findings

What research findings exist regarding Dermorphin in nociception and analgesic mechanisms?

Dermorphin produces anti-nociceptive effects, revealing the role of receptor internalization. Other studies report: increasing nociceptive flexion reflex threshold, providing physiological evidence related to analgesia.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
2 Main ReferencesSorted by First Publication Date ↓
Animal Study2010 · Historical basic researchREF. 01

What is the relationship between receptor internalization and Dermorphin anti-injury sensation?

Research Findings

Dermorphin produces anti-nociceptive effects, revealing the role of receptor internalization.[1] ↗

Study Design

Administration and receptor experiments in periaqueductal gray matter of animals.

Scope & Limitations

Special intracerebral local administration; not efficacy proof of regular systemic administration.

View the Article Title and Full Citation+

Opioid receptor internalization contributes to dermorphin-mediated antinociception.

Macey TA, Ingram SL, Bobeck EN, Hegarty DM, Aicher SA, Arttamangkul S, Morgan MM.

Neuroscience · Volume/Issue Year 2010
First published on 2010-04-13 · PMID 20394808
DOI 10.1016/j.neuroscience.2010.04.003

Human Study1986 · historical basic researchREF. 02

What do early human harmful reflex experiments indicate?

Research Findings

Increase the threshold of harmful flexion reflex, providing physiological evidence related to analgesia.[2] ↗

Study Design

Human healthy volunteers and spinal cord injury subjects; intravenous administration

Scope & Limitations

Early experimental studies in 1986; not modern clinical pain relief or safety confirmation.

View the Article Title and Full Citation+

Dermorphin inhibits spinal nociceptive flexion reflex in humans.

Sandrini G, Degli Uberti EC, Salvadori S, Margutti A, Trasforini G, Tomatis R, Nappi G, Pansini R.

Brain Research · Volume/Issue Year 1986
First published 1986-04-01 · PMID 3697765.
DOI 10.1016/0006-8993(86)90376-8

i

Currently, 2 original studies related to the theme of this page have been selected. Fewer than 3, leaving a gap, no supplementation from other sources. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

GO DEEPER

What Questions Do These Studies Address?

Compare study populations, findings and scope.

↗
QUESTIONS, ANSWERED

Dermorphin · Frequently Asked Questions.

What research findings exist regarding Dermorphin in nociception and analgesic mechanisms?+

Dermorphin produces anti-nociceptive effects, revealing the role of receptor internalization. Other studies report: increasing nociceptive flexion reflex threshold, providing physiological evidence related to analgesia.[1] ↗ [2] ↗

Do the analgesic physiological results of Dermorphin equal clinical pain control protocols?+

Not equal. Selected data involve early human reflex experiments and special intracerebral local drug delivery animal models, which do not support clinical use or safety claims of ordinary formulations.[2] ↗ [1] ↗

Dermorphin—these conclusions apply to which study populations?+

Administration and receptor experiments in periaqueductal gray matter of animals; healthy human volunteers and spinal cord injury participants; intravenous administration. Special intracerebral local administration; not evidence of efficacy from standard systemic administration.[1] ↗ [2] ↗

VENTRO PEPTIDES & BIOTECH · RESEARCH PRODUCT RETAIL

Research peptides. Shop by product.

Compare specifications, reference prices and COA reports. Add products to your cart to request a quote.

Ventro Peptides & Biotech Logo
QUALITY DOCUMENTSCOA BY PRODUCTGLOBAL DELIVERYTECHNICAL SUPPORT

01 / CATALOG

Browse products

7 products Product names, specifications, and prices follow the current quotation
SemaglutideSM10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Semaglutide

10mg/vial x 10vials

US$90.91
TirzepatideTR20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Tirzepatide

20mg/vial x 10vials

US$160.61
RetatrutideRT10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Retatrutide

10mg/vial x 10vials

US$109.09
BPC157BC10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Repair & Recovery Research

BPC157

10mg/vial x 10vials

US$133.33
MOTS-CMS20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Longevity & Mitochondrial Research

MOTS-C

20mg/vial x 10vials

US$257.58
LiraglutideLR10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Liraglutide

10mg*10vials

US$164.71
IGF-lr3IG1COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

IGF-lr3

1mg/vial x 10vials

US$505.88

03 / ABOUT VENTRO

Reliable peptide supply, built for long-term partnerships.

Ventro supports research product retail purchases with clear pack specifications, available quality documents, and responsive international support.

  • High-purity peptides
  • Available COA reports
  • COA & quality documentation
  • Flexible small-quantity purchases
  • Reliable global fulfillment
  • Research product retail support

04 / QUALITY SYSTEM

Quality without compromise

Browse the available COA reports by product. Confirm documentation for your order with our team.

Controlled quality workflowRaw material to final release
Responsive global supportProduct matching and technical support

RESEARCH PRODUCT INQUIRY

Submit a product inquiry

Tell us the product, specification, and expected quantity. Our team will respond with pricing and available documents.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

Contact Ventro

Choose a channel to contact the Ventro team directly.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

WhatsApp